1. Home >
  2. M&A >
  3. Going Private >
  4. France >
  5. Seqens Acquires PCAS

M&A Deal Summary

Seqens Acquires PCAS

On September 7, 2023, Seqens acquired chemicals company PCAS

Acquisition Highlights
  • This is Seqens’ 2nd transaction in the Chemicals sector.
  • This is Seqens’ 1st transaction in France.

M&A Deal Summary
Date 2023-09-07
Target PCAS
Sector Chemicals
Buyer(s) Seqens
Deal Type Going Private

Target

PCAS

Longjumeau, France
PCAS is an international fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. PCAS was founded in 1962 and is based in Longjumeau, France.

Search 205,705 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Seqens

Ecully, France
Category Company
Founded 2003
Sector Chemicals
Employees3,200
Revenue 470M EUR (2010)
DESCRIPTION

Seqens is a global diversified chemicals Group that produces and distributes essential chemicals that are used in everyday products. Seqens offers a broad portfolio of active ingredients, pharmaceutical intermediates, and specialty ingredients, develops and industrializes the most demanding molecules, and relies on its ability to innovate, develop and implement the best available technologies. Seqens was founded in 2003 and is based in Ecully, France.

DEAL STATS #
Overall 5 of 5
Sector (Chemicals) 2 of 2
Type (Going Private) 1 of 1
Country (France) 1 of 1
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-26 Wavelength Pharmaceuticals

Petah Tikva, Israel

Wavelength Pharmaceuticals is a developer and manufacturer of generic APIs and finished dose forms (“FDF”) with operations primarily located in Israel and supporting functions in the U.S. and India. The Business has a global customer base and a broad array of products that leverage its specialized manufacturing capabilities and core competency in complex chemistries. Wavelength Pharmaceuticals is based in Petah Tikva, Israel.

Buy -
Mergr

Product

Company

Legal